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Achromatopsia is an autosomal recessively inherited visual disorder that is present from birth and that features the
absence of color discrimination. We here report the identification of five independent families with achromatopsia
that segregate protein-truncation mutations in the GNAT2 gene, located on chromosome 1p13. GNAT2 encodes
the cone photoreceptor–specific a-subunit of transducin, a G-protein of the phototransduction cascade, which
couples to the visual pigment(s). Our results demonstrate thatGNAT2 is the third gene implicated in achromatopsia.
Achromatopsia, also referred to as “rod monochromacy”
(ACHM2 [MIM 216900] and ACHM3 [MIM 262300]),
is a congenital ocular disorder characterized by total color
blindness, low visual acuity, photophobia, and nystag-
mus. It is inherited as an autosomal recessive trait, with
an estimated prevalence of 1/30,000 (Franc¸ois 1961).
Recently, we and others have shown that mutations
in CNGA3 and CNGB3, which encode the a- and b-
subunits of the cone photoreceptor cGMP-gated chan-
nel, cause clinically indistinguishable forms of achroma-
topsia, including Pingelapese blindness (Kohl et al. 1998,
2000; Sundin et al. 2000).
However, screening for CNGA3 and CNGB3 muta-
tions in a large cohort of patients with achromatopsia
revealed further genetic heterogeneity in approximately
one-third of the cases. The pursuit of additional genes
involved in achromatopsia led us to consider GNAT2
as a prime candidate gene, because of its cone pho-
toreceptor specificity and functional importance in the
visual transduction process (Lerea et al. 1986; Blatt et
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al. 1988; Morris and Fong 1993). GNAT2 encodes the
cone-specific a-subunit of transducin (MIM 139340), a
heterotrimeric G-protein that couples to the cone visual
pigments. Excited pigment molecules induce both the
exchange of GDP to GTP at the guanosine-binding site
of the transducin a-subunit and its subsequent release
from the inhibitory b/g-subunits. The activated GTP •
transducin complex then binds and activates a phos-
phodiesterase that hydrolyzes cGMP and thereby effec-
tively reduces its intracellular concentration. This results
in closure of the cGMP-gated channels and, subse-
quently, in membrane hyperpolarization (Mu¨ller and
Kaupp 1998). Transducin thus mediates one of the first
steps of the phototransduction cascade, whereas the
cGMP-gated channel represents the final component of
the very same process.
It has been shown that a missense mutation inGNAT1,
which encodes the rod photoreceptor–specific transducin
a-subunit, is implicated in autosomal dominant congen-
ital stationary night blindness of Nougaret (Dryja et al.
1996), and a homologous phenotype has been described
for the corresponding knockout-mouse model (Calvert et
al. 2000). In contrast, no association between theGNAT2
locus and hereditary retinal disorders has been detected
in previous studies (Gerber et al. 1995; Magovcevic et al.
1995). The human GNAT2 gene comprises eight exons
and covers ∼10 kb of genomic sequence on human chro-
mosome 1p13. GNAT2 encodes a polypeptide of 354
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Table 1
Sequences of PCR Primers Used to Amplify GNAT2 Coding Segments
EXON(S)
PRIMER
PCR
PRODUCT SIZE
(bp)Forward Reverse
1 GCTTTTAGGGGAGCCAAGTT CCCCTAGCCAGACTGTGTAGA 452
2 and 3 CCCCCAAGCAAGCAG CAGCAGGTGGGATTTTAGTT 691
4 TCTGCATCTGGGGAGCATAC TTGGGTTGGGTGAGGTTT 434
5 and 6 TGGCTTCTAGTCCTGAGGTC GATTGGTCTGCTGGAGG 716
7 and 8 TTTTTACATTTGGAGCACTG CCCACTTTGAAAAGAACG 1,023
IVS 3–5a TTAAGGTAGACGGTACCTTTC TAAGGTCTTACTGCGTAGATG 2,022
a Amplification was by long-distance PCR.
Table 2
Mutations in GNAT2 in Patients with Achromatopsia
EXON
ALTERATIONa
Nucleotide Sequence Polypeptide (Consequence)
3 c.235CrT p.Q79X
3 c.285_291del7insCTGTAT p.Y95fsX61
4 IVS3365_IVS4974del Exon 4 deleted (p.A101fsX12)
5 c.503_504insT p.L168fsX3
7 c.802_803insTCAA p.L268fsX9
8 c.955delA p.I319fsX5
a Nomenclature is according to previous recommendations (den
Dunnen and Antonarakis 2001). The reference sequence is from
GenBank (accession number Z18859).
amino acid residues that shows 82% sequence identity
with its paralog in rod photoreceptors (Lerea et al. 1989;
Kubo et al. 1991; Morris and Fong 1993).
We screened the entire coding sequence of the GNAT2
gene, in a collection of 77 unrelated patients with ach-
romatopsia, in whom mutations in the CNGA3 and
CNGB3 genes were excluded. PCR fragments covering
all eight exons and flanking intron/UTR sequences of
GNAT2 were amplified from genomic DNA (for primer
sequences, see table 1) and were subjected to direct DNA
sequencing employing Big Dye Terminator chemistry (Ap-
plied Biosystems). Reaction products were separated on
an ABI 3100 DNA sequencer, and sequences were ana-
lyzed by the Lasergene Software package (DNASTAR).
In the 77 patients with achromatopsia whom we an-
alyzed, we were able to identify six different disease-re-
lated sequence alterations (table 2) segregating in five
independent families of European descent (fig. 1a and
b). The mutations comprise one nonsense mutation,
c.235CrT (p.Q75X), and four small deletion and/or in-
sertion mutations, which all cause frameshifts and lead
to premature translation termination. The sixth muta-
tion represents a large intragenic deletion of 2,019 bp
(g.3407_5425del [GenBank accession number Z18859]),
which includes exon 4 and flanking intron sequences. This
deletion probably results from a recombination between
two 229-bp direct-repeat sequences present in intron 3
and intron 4 of GNAT2 (fig. 1c). BLASTN analysis re-
vealed that this repeat is unique to the GNAT2 locus, on
chromosome 1p13. Detection of the deletion and analysis
of its segregation in family CHRO22 were easily accom-
plished by long-distance PCR (fig.1b and table 1).
In four of the five families, patients apparently carry
homozygous mutations. The presence of heterozygous
mutations in both parents could be shown by segregation
analysis in families CHRO22 and CHRO87 (fig. 1a and
b). Moreover, parental consanguinity is documented in
families CHRO22 and CHRO94. We also noticed that,
in the remaining two families, CHRO68 and CHRO87,
both parents traced their ancestry back to the same ge-
ographic region in southern Italy and Denmark, respec-
tively. Therefore, we think that, in the end, consanguinity
exists between those parents too, albeit earlier than
known family history.
All the observed mutations result in premature trans-
lation termination and in mutant polypeptides that lack
considerable portions of the genuine carboxy terminus.
It has been shown that the conserved carboxy terminus
of the rod photoreceptor paralog contains major sites of
interaction with the excited rod photopigment (Cai et al.
2001). Considering the high conservation between the rod
and cone transducin a-subunits, a similar structural func-
tion can be assumed to exist in the cone system. We there-
fore argue that the mutations represent functional null
alleles of GNAT2, which prevent either the formation of
the trimeric G-protein complex or its interaction with the
excited photopigments.
Notably, all genes now known to be involved in ach-
romatopsia encode crucial components of the cone pho-
totransduction cascade. Because of the lack of cone func-
tion in patients with achromatopsia, it is reasonable to
argue that, like the cone-specific cGMP-gated channel,
all three different types of human cone photoreceptors
utilize a common transducin a-subunit and that there is
functional conservation of the phototransduction pro-
cess in cones.
The present study provides convincing evidence that
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Figure 1 GNAT2 mutations in families segregating achromatopsia. A and B, Pedigrees of the five achromatopsia families with GNAT2
mutations, including the genotypes of available subjects (denoted by asterisks [*]) as determined by segregation analysis.  p wild type;  p
mutation. The geographical origin of the families is indicated by square brackets: Ip Italy; DKp Denmark; Dp Germany; TKp Turkey. Panel
b presents the results of segregation analysis of the exon 4 deletion in family CHRO22. The photograph shows the electrophoretic separation of
wild-type alleles (upper band) and mutant alleles (lower band), after amplification by long-distance PCR. Mpmarker; Cp normal control subject.
C, Organization of the GNAT2 gene (top) and location of the two repeats (R1 and R2) putatively implicated in the exon 4 deletion (bottom). D,
Electropherograms of mutant sequence (bottom) and corresponding wild-type reverse-strand sequence (top), for homozygous mutations c.235CrT
(p.Q79X) and c.285_291del7insCTGTAT and for heterozygous mutation c.955delA. Mutation sites are indicated by arrows (f).
mutations in the GNAT2 gene cause achromatopsia. Pa-
tients with mutations in GNAT2 show a phenotype typ-
ical of achromatopsia, with low visual acuity, photo-
phobia, nystagmus, and absent or barely detectable cone
function in electroretinographic recordings and psycho-
physical color-vision testing. Genetic classification now
allows further detailed clinical studies to investigate
whether there are phenotypic differences that distin-
guish between GNAT2-associated and other forms of
achromatopsia.
GNAT2 is the third gene found to be implicated in
achromatopsia. Considering that our complete sample
of patients consists of nearly 280 unrelated patients with
achromatopsia, mutations in the GNAT2 gene are re-
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sponsible for !2% of all patients affected by this dis-
order. Compared with the other two genes known to
cause achromatopsia—CNGA3 and CNGB3, which ac-
count for ∼20%–30% and ∼40%–50% of the cases,
respectively (Wissinger et al. 2001; authors’ unpublished
data)—GNAT2 is only a minor achromatopsia locus.
This emphasizes what we call the “orphan disease-gene
concept,” which is based on the exclusion of known
common disease genes in order to define a subset of
patients for subsequent identification of rare disease
genes. This will not only improve genetic diagnostics but
also provide examples of the effect of mutations in a
particular gene and, thereby, increase our knowledge
about the pathophysiological spectrum of human genetic
disorders.
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